Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Return on Equity (2016 - 2017)

Historic Return on Equity for Soleno Therapeutics (SLNO) over the last 5 years, with Q3 2018 value amounting to 0.04%.

  • Soleno Therapeutics' Return on Equity rose 1300.0% to 0.04% in Q3 2018 from the same period last year, while for Sep 2018 it was 0.04%, marking a year-over-year increase of 1300.0%. This contributed to the annual value of 0.05% for FY2018, which is 1900.0% up from last year.
  • According to the latest figures from Q3 2018, Soleno Therapeutics' Return on Equity is 0.04%, which was up 1300.0% from 0.09% recorded in Q2 2018.
  • Soleno Therapeutics' Return on Equity's 5-year high stood at 2.87% during Q3 2015, with a 5-year trough of 12.58% in Q4 2015.
  • For the 5-year period, Soleno Therapeutics' Return on Equity averaged around 1.13%, with its median value being 0.14% (2017).
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -129300bps in 2015, then surged by 109300bps in 2016.
  • Soleno Therapeutics' Return on Equity (Quarter) stood at 0.35% in 2014, then crashed by -3728bps to 12.58% in 2015, then surged by 87bps to 1.66% in 2016, then soared by 91bps to 0.14% in 2017, then skyrocketed by 75bps to 0.04% in 2018.
  • Its Return on Equity was 0.04% in Q3 2018, compared to 0.09% in Q2 2018 and 0.11% in Q1 2018.